RESUMO
BACKGROUND: Propofol is commonly used to provide anaesthesia for children undergoing oesophagogastroduodenoscopy (OGD). Despite this, the plasma concentration-response relationships for propofol used in this setting have not been established. METHODS: In order to determine the EC50 of propofol during OGD, we studied 12 children aged 3-10 years. No premedication was given. Propofol was administered via a target-controlled infusion system using the STANPUMP software based on a paediatric pharmacokinetic model. The 'up-and-down' method described by Dixon was used to determine the EC50. Accordingly, the target plasma propofol concentration for each patient, beginning with the second subject, was determined by the response of the previous patient. A patient was considered a 'responder' if there was minimal movement and the heart rate (HR) and blood pressure (BP) remained < or = 120% of baseline during the procedure. Patients who moved excessively, i.e. requiring more than gentle restraint, or who manifest HR and BP >120% of baseline, were considered 'nonresponders'. RESULTS: The EC50 of propofol during OGD was 3.55 microg.ml(-1) in this study. CONCLUSIONS: The plasma propofol concentration associated with adequate anaesthesia for OGD in 50% of unpremedicated children is 3.55 microg.ml(-1). This concentration is higher than that required for OGD in adult patients.
Assuntos
Anestesia Intravenosa , Anestésicos Intravenosos/administração & dosagem , Endoscopia Gastrointestinal , Propofol/administração & dosagem , Anestesia Intravenosa/efeitos adversos , Anestesia Intravenosa/métodos , Anestésicos Intravenosos/sangue , Criança , Pré-Escolar , Desenho de Equipamento , Esofagite/diagnóstico , Feminino , Frequência Cardíaca , Humanos , Bombas de Infusão , Masculino , Propofol/sangueRESUMO
Tracheal extubation of patients with a difficult airway represents a challenge to anaesthesiologists and intensive care physicians. While a variety of techniques designed to maintain access to the airway in case of the need for tracheal reintubation have been described in adults, no reports have been published in infants and young children. We describe an approach to this issue in a young child with severe micrognathia.
Assuntos
Anestesia Geral , Intubação Intratraqueal/métodos , Micrognatismo , Anormalidades Múltiplas , Obstrução das Vias Respiratórias/etiologia , Cateterismo Cardíaco , Pré-Escolar , Dexametasona/uso terapêutico , Edema/tratamento farmacológico , Humanos , Intubação Intratraqueal/efeitos adversos , Masculino , Micrognatismo/complicações , Fatores de RiscoAssuntos
Anestesia , Procedimentos Cirúrgicos Torácicos , Adolescente , Criança , Pré-Escolar , Humanos , Lactente , Recém-Nascido , Respiração ArtificialRESUMO
The use of regional anesthesia in combination with general anesthesia for children undergoing cardiac surgery is receiving increasing attention from clinicians. The addition of regional anesthesia may improve clinical outcomes and decrease costs as a result of the reduced need for postoperative mechanical ventilation. The goal of this retrospective chart review was to evaluate whether spinal anesthesia (SAB) or epidural anesthesia (EPID) in combination with general anesthesia was associated with circulatory stability, satisfactory postoperative sedation/analgesia, and a low incidence of adverse effects. The medical records of 50 consecutive children having open heart surgery with SAB or EPID and general anesthesia between September 1996 and December 1997 were reviewed. We found no significant differences in the incidence of clinically significant changes in vital signs, oxygen desaturation, hypercarbia, or vomiting. Patients in the SAB group received significantly more sedative/analgesic interventions than those in the EPID group.
Assuntos
Anestesia por Condução , Anestesia Geral , Procedimentos Cirúrgicos Cardíacos , Anestesia por Condução/efeitos adversos , Anestesia por Condução/métodos , Anestesia Epidural/efeitos adversos , Anestesia Geral/efeitos adversos , Raquianestesia/efeitos adversos , Anestésicos Locais , Bupivacaína/administração & dosagem , Criança , Pré-Escolar , Feminino , Cardiopatias Congênitas/cirurgia , Humanos , Lactente , Tempo de Internação , Masculino , Estudos RetrospectivosAssuntos
Respiração Artificial/métodos , Adolescente , Adulto , Brônquios/anatomia & histologia , Criança , Pré-Escolar , Humanos , Lactente , Intubação Intratraqueal/instrumentação , Intubação Intratraqueal/métodos , Intubação Intratraqueal/normas , Pediatria/instrumentação , Pediatria/métodos , Guias de Prática Clínica como Assunto , Respiração Artificial/instrumentação , Respiração Artificial/normas , Traqueia/anatomia & histologiaRESUMO
Tracheal intubation of a child with trismus pseudocamptodactyly (Hecht) syndrome is described. This disorder is characterized by progressive trismus and the need for repeated surgeries. Children intubated orally on a prior occasion may require an alternative approach subsequently due to progressive inability to open the mouth. An antegrade fiberoptic-guided nasotracheal technique initially was chosen due to extremely limited mouth opening. After this approach was unsuccessful, a retrograde guidewire-assisted fiberoptic intubation was performed. The manifestations of Hecht syndrome, as well as both techniques for tracheal intubation employed, are reviewed.
Assuntos
Anormalidades Craniofaciais/cirurgia , Trismo/cirurgia , Criança , Progressão da Doença , Tecnologia de Fibra Óptica , Humanos , Intubação Intratraqueal/métodos , Masculino , SíndromeAssuntos
Anestesia Epidural , Raquianestesia , Procedimentos Cirúrgicos Cardíacos , Analgesia/efeitos adversos , Analgesia/economia , Analgesia/métodos , Analgesia Epidural/efeitos adversos , Analgesia Epidural/economia , Analgesia Epidural/métodos , Anestesia Epidural/efeitos adversos , Anestesia Epidural/economia , Anestesia Epidural/métodos , Raquianestesia/efeitos adversos , Raquianestesia/economia , Raquianestesia/métodos , Criança , Análise Custo-Benefício , Hematoma/etiologia , Humanos , Hipotensão/etiologia , Dor Pós-Operatória/prevenção & controle , Insuficiência Respiratória/etiologia , Estresse Fisiológico/prevenção & controleRESUMO
A Univent bronchial blocker tube was used in a ten-year-old patient undergoing videothoracoscopy. Paediatric Univent tubes offer an alternative to balloon-tipped catheters for providing single-lung ventilation (SLV) in children too small for adult size double-lumen tubes.
Assuntos
Brônquios , Intubação/instrumentação , Respiração Artificial/instrumentação , Criança , Endoscopia , Feminino , Humanos , Respiração Artificial/métodos , Toracoscopia , Gravação em VídeoRESUMO
BACKGROUND: Nationally, results of renal transplantation in children, particularly in small children, are inferior to those obtained in adults. OBJECTIVE: To determine factors important for success in renal transplantation in children. DESIGN: Results of 108 consecutive renal transplantations performed in patients aged 7 months to 18 years were reviewed and compared with those reported by the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS), the national registry. RESULTS: One-, 2-, and 3-year graft survival rates (+/-SE) were 99% +/- 1%, 95% +/- 3%, and 93% +/- 4%, respectively, for living donor grafts and 97% +/- 3%, 92% +/- 6%, and 92% +/- 6%, respectively, for cadaver grafts. Incidence of acute rejection was half that reported by NAPRTCS. There were no graft losses for technical reasons (19% in NAPRTCS). Twelve percent of patients were younger than 2 years (6% in NAPRTCS); 17% were 2 to 5 years old (16% in NAPRTCS). Most small children received an adult-sized kidney. Ninety-three percent of recipients weighing 15 kg or less received postoperative mechanical ventilation assistance to optimize fluid resuscitation and perfusion of adult-sized kidneys. Structural abnormalities of the urinary tract were present in 53.7% of the patients (48.5% in NAPRTCS; adults, 5.3%). Nephroureterectomy was required in 38 children; in 27 (71%) of them, it was performed at the time of transplant surgery. CONCLUSIONS: Excellent results can be obtained in pediatric renal transplantation by strict adherence to surgical detail, tight immunosuppressive management, aggressive fluid management in the small child, and careful integration of urologic and transplant surgery.
Assuntos
Transplante de Rim/mortalidade , Adolescente , Criança , Pré-Escolar , Protocolos Clínicos , Rejeição de Enxerto/epidemiologia , Sobrevivência de Enxerto , Humanos , Terapia de Imunossupressão , Incidência , Lactente , Transplante de Rim/efeitos adversos , Complicações Pós-Operatórias/epidemiologia , Taxa de Sobrevida , Resultado do Tratamento , Sistema Urinário/anormalidades , Sistema Urinário/cirurgiaRESUMO
The technical and medical management of small infants requiring orthotopic liver transplantation remains a challenge. The present study examined 117 orthotopic liver transplantations performed in 101 infants from <1 to 23 months of age between March 1988 and February 1995 to determine factors that influence patient and graft outcome. Factors analyzed included etiology of liver disease, recipient and donor age and weight, United Network for Organ Sharing (UNOS) status, retransplantation, ABO-compatibility, full-size (FS) versus reduced-size grafts, vascular thrombosis (VT), including hepatic artery and portal vein (PVT), and the presence of lymphoproliferative disease (LPD). UNOS status 1, fulminant hepatic failure, and the development of Epstein-Barr virus-associated LPD were each associated with 10-20% lower patient and graft survival rates. Of 101 infants, 11 (11%) developed LPD with an associated 36% mortality. VT occurred in 10 (9 hepatic artery and 1 portal vein) of 117 orthotopic liver transplantations (9%), all less than 1 year of age, and was associated with significantly poorer 1-year (50% vs. 85% no VT, P<0.01) and 5-year patient survival rates (50% vs. 83% no VT, P<0.01). One-year graft survival rates for FS grafts in recipients <12 months versus 12-23 months were 67% vs. 94% (P<0.01); the patient survival rate was also significantly lower in FS graft recipients <12 months (76% vs. 100%, P<0.05). Recipients <5 months of age had the worst survival rates: 1-year and 5-year patient survival rates were 65% and 46% for recipients 0-4 months (n=17) versus 82% and 82% for recipients 5-11 months (n=56), and 93% and 93% for recipients age 12-23 months (n=28; P<0.05). In summary, factors associated with reduced survival rates include recipient age <5 months, recipient age <12 months who received FS grafts, development of VT and donor weight <6 kg. There was a trend for UNOS status 1, fulminant hepatic failure, and presence of LPD to be associated with reduced survival rates.
Assuntos
Transplante de Fígado/mortalidade , Envelhecimento/fisiologia , Soro Antilinfocitário/uso terapêutico , Causas de Morte , Ciclosporina/uso terapêutico , Rejeição de Enxerto/etiologia , Rejeição de Enxerto/prevenção & controle , Sobrevivência de Enxerto/fisiologia , Humanos , Lactente , Transplante de Fígado/efeitos adversos , Transplante de Fígado/imunologia , Transtornos Linfoproliferativos/etiologia , Transtornos Linfoproliferativos/mortalidade , Veia Porta , Estudos Retrospectivos , Taxa de Sobrevida , Trombose/etiologiaAssuntos
Falência Renal Crônica/cirurgia , Transplante de Rim/métodos , Complicações Pós-Operatórias , Doenças da Bexiga Urinária/cirurgia , Bexiga Urinária/cirurgia , Adolescente , Adulto , Criança , Pré-Escolar , Humanos , Estudos Retrospectivos , Resultado do Tratamento , Ureter/cirurgia , Ureter/transplanteAssuntos
Respiração Artificial , Insuficiência Respiratória/terapia , Administração por Inalação , Criança , Pré-Escolar , Oxigenação por Membrana Extracorpórea , Fluorocarbonos/uso terapêutico , Humanos , Hipnóticos e Sedativos/uso terapêutico , Lactente , Recém-Nascido , Intubação Intratraqueal , Fármacos Neuromusculares Despolarizantes/uso terapêutico , Fármacos Neuromusculares não Despolarizantes/uso terapêutico , Óxido Nítrico/uso terapêutico , Surfactantes Pulmonares/uso terapêutico , Respiração Artificial/métodos , Fenômenos Fisiológicos Respiratórios , Sistema Respiratório/anatomia & histologia , Desmame do RespiradorRESUMO
Ten consecutive patients with failure of urinary bladder augmentation (UBA) performed either prior to or after reaching end-stage renal disease (ESRD) were studied. Seven patients developed increased hydroureteronephrosis, infectious complications, and advanced to ESRD after UBA. The mean time to development of ESRD in patients who had UBA performed with moderate chronic renal failure (CRF) was 1.8 years. The UBAs in all seven patients were taken down prior to transplantation. Subsequently, five of these UBA-takedown patients have received kidney grafts and all have stable, good renal function. Three patients had their UBA performed after they reached ESRD, in preparation for renal transplantation. All three of these patients experienced recurrent urosepsis following transplantation, resulting in death in one patient and loss of graft in another. The third patient will undergo takedown of the UBA. This study suggests that UBA may possibly not be the best option for patients with moderate CRF and those awaiting transplantation.